306 related articles for article (PubMed ID: 17699851)
1. Secreted frizzled-related protein 1 loss contributes to tumor phenotype of clear cell renal cell carcinoma.
Gumz ML; Zou H; Kreinest PA; Childs AC; Belmonte LS; LeGrand SN; Wu KJ; Luxon BA; Sinha M; Parker AS; Sun LZ; Ahlquist DA; Wood CG; Copland JA
Clin Cancer Res; 2007 Aug; 13(16):4740-9. PubMed ID: 17699851
[TBL] [Abstract][Full Text] [Related]
2. Functional significance of secreted Frizzled-related protein 1 in metastatic renal cell carcinomas.
Saini S; Liu J; Yamamura S; Majid S; Kawakami K; Hirata H; Dahiya R
Cancer Res; 2009 Sep; 69(17):6815-22. PubMed ID: 19723665
[TBL] [Abstract][Full Text] [Related]
3. Methylation-associated silencing of SFRP1 in renal cell carcinoma.
Awakura Y; Nakamura E; Ito N; Kamoto T; Ogawa O
Oncol Rep; 2008 Nov; 20(5):1257-63. PubMed ID: 18949430
[TBL] [Abstract][Full Text] [Related]
4. Loss of secreted frizzled-related protein-1 expression in renal cell carcinoma reveals a critical tumor suppressor function.
Rubin JS; Bottaro DP
Clin Cancer Res; 2007 Aug; 13(16):4660-3. PubMed ID: 17699841
[No Abstract] [Full Text] [Related]
5. Frequent loss of SFRP1 expression in multiple human solid tumours: association with aberrant promoter methylation in renal cell carcinoma.
Dahl E; Wiesmann F; Woenckhaus M; Stoehr R; Wild PJ; Veeck J; Knüchel R; Klopocki E; Sauter G; Simon R; Wieland WF; Walter B; Denzinger S; Hartmann A; Hammerschmied CG
Oncogene; 2007 Aug; 26(38):5680-91. PubMed ID: 17353908
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic inactivation of the canonical Wnt antagonist secreted frizzled-related protein 1 in hepatocellular carcinoma cells.
Wu Y; Li J; Sun CY; Zhou Y; Zhao YF; Zhang SJ
Neoplasma; 2012; 59(3):326-32. PubMed ID: 22296502
[TBL] [Abstract][Full Text] [Related]
7. The SFRP family of WNT inhibitors function as novel tumor suppressor genes epigenetically silenced in medulloblastoma.
Kongkham PN; Northcott PA; Croul SE; Smith CA; Taylor MD; Rutka JT
Oncogene; 2010 May; 29(20):3017-24. PubMed ID: 20208569
[TBL] [Abstract][Full Text] [Related]
8. Blockade of Wnt signaling inhibits angiogenesis and tumor growth in hepatocellular carcinoma.
Hu J; Dong A; Fernandez-Ruiz V; Shan J; Kawa M; Martínez-Ansó E; Prieto J; Qian C
Cancer Res; 2009 Sep; 69(17):6951-9. PubMed ID: 19690140
[TBL] [Abstract][Full Text] [Related]
9. Expression of secreted frizzled-related protein 1 and 3, T-cell factor 1 and lymphoid enhancer factor 1 in clear cell renal cell carcinoma.
Nikuševa-Martić T; Serman L; Zeljko M; Vidas Z; Gašparov S; Zeljko HM; Kosović M; Pećina-Šlaus N
Pathol Oncol Res; 2013 Jul; 19(3):545-51. PubMed ID: 23572277
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus core protein epigenetically silences SFRP1 and enhances HCC aggressiveness by inducing epithelial-mesenchymal transition.
Quan H; Zhou F; Nie D; Chen Q; Cai X; Shan X; Zhou Z; Chen K; Huang A; Li S; Tang N
Oncogene; 2014 May; 33(22):2826-35. PubMed ID: 23770846
[TBL] [Abstract][Full Text] [Related]
11. Reexpression of tumor suppressor, sFRP1, leads to antitumor synergy of combined HDAC and methyltransferase inhibitors in chemoresistant cancers.
Cooper SJ; von Roemeling CA; Kang KH; Marlow LA; Grebe SK; Menefee ME; Tun HW; Colon-Otero G; Perez EA; Copland JA
Mol Cancer Ther; 2012 Oct; 11(10):2105-15. PubMed ID: 22826467
[TBL] [Abstract][Full Text] [Related]
12. DNA methyltransferase inhibitor-mediated apoptosis in the Wnt/β-catenin signal pathway in a renal cell carcinoma cell line.
Konac E; Varol N; Yilmaz A; Menevse S; Sozen S
Exp Biol Med (Maywood); 2013 Sep; 238(9):1009-16. PubMed ID: 23975733
[TBL] [Abstract][Full Text] [Related]
13. SFRP1 suppressed hepatoma cells growth through Wnt canonical signaling pathway.
Shih YL; Hsieh CB; Lai HC; Yan MD; Hsieh TY; Chao YC; Lin YW
Int J Cancer; 2007 Sep; 121(5):1028-35. PubMed ID: 17443492
[TBL] [Abstract][Full Text] [Related]
14. Functional analyses and prognostic significance of SFRP1 expression in bladder cancer.
Rogler A; Kendziorra E; Giedl J; Stoehr C; Taubert H; Goebell PJ; Wullich B; Stöckle M; Lehmann J; Petsch S; Hartmann A; Stoehr R
J Cancer Res Clin Oncol; 2015 Oct; 141(10):1779-90. PubMed ID: 25732201
[TBL] [Abstract][Full Text] [Related]
15. Aberrant methylation of the Wnt antagonist SFRP1 in breast cancer is associated with unfavourable prognosis.
Veeck J; Niederacher D; An H; Klopocki E; Wiesmann F; Betz B; Galm O; Camara O; Dürst M; Kristiansen G; Huszka C; Knüchel R; Dahl E
Oncogene; 2006 Jun; 25(24):3479-88. PubMed ID: 16449975
[TBL] [Abstract][Full Text] [Related]
16. SFRP1 CpG island methylation locus is associated with renal cell cancer susceptibility and disease recurrence.
Atschekzei F; Hennenlotter J; Jänisch S; Großhennig A; Tränkenschuh W; Waalkes S; Peters I; Dörk T; Merseburger AS; Stenzl A; Kuczyk MA; Serth J
Epigenetics; 2012 May; 7(5):447-57. PubMed ID: 22419128
[TBL] [Abstract][Full Text] [Related]
17. DOG1, cyclin D1, CK7, CD117 and vimentin are useful immunohistochemical markers in distinguishing chromophobe renal cell carcinoma from clear cell renal cell carcinoma and renal oncocytoma.
Zhao W; Tian B; Wu C; Peng Y; Wang H; Gu WL; Gao FH
Pathol Res Pract; 2015 Apr; 211(4):303-7. PubMed ID: 25596994
[TBL] [Abstract][Full Text] [Related]
18. Investigation of tumor suppressor genes apart from VHL on 3p by deletion mapping in sporadic clear cell renal cell carcinoma (cRCC).
Singh RB; Amare Kadam PS
Urol Oncol; 2013 Oct; 31(7):1333-42. PubMed ID: 21962529
[TBL] [Abstract][Full Text] [Related]
19. Secreted frizzled-related protein-5 is epigenetically downregulated and functions as a tumor suppressor in kidney cancer.
Kawakami K; Yamamura S; Hirata H; Ueno K; Saini S; Majid S; Tanaka Y; Kawamoto K; Enokida H; Nakagawa M; Dahiya R
Int J Cancer; 2011 Feb; 128(3):541-50. PubMed ID: 20340127
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of SFRP1 as a putative tumor suppressor gene can contribute to human hepatocellular carcinoma.
Huang J; Zhang YL; Teng XM; Lin Y; Zheng DL; Yang PY; Han ZG
BMC Cancer; 2007 Jul; 7():126. PubMed ID: 17626620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
